An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients.
Salomon
D R
DR
Laboratory of Immunology, National Institutes of Health, Bethesda, Maryland, NIAID 20892.
D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D005431:Florida; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D012189:Retrospective Studies
D003524:Cyclosporins